FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220653025> ?p ?o ?g. }

• W4220653025 endingPage "173" @default.
• W4220653025 startingPage "161" @default.
• W4220653025 abstract "Abstract Purpose Although adjuvant systemic therapy (AST) helps increase breast cancer-specific survival (BCSS), there is a growing concern for overtreatment. By estimating the expected BCSS of AST using PREDICT, this study aims to quantify the number of patients treated with AST without benefit to provide estimates of overtreatment. Methods Data of all non-metastatic unilateral breast cancer patients diagnosed in 2015 were retrieved from cancer registries from The Netherlands and the USA. The PREDICT tool was used to estimate AST survival benefit. Overtreatment was defined as the proportion of patients that would have survived regardless of or died despite AST within 10 years. Three scenarios were evaluated: actual treatment, and recommendations by the Dutch or USA guidelines. Results 59.5% of Dutch patients were treated with AST. 6.4% (interquartile interval [IQI] = 2.5, 8.2%) was expected to survive at least 10 years due to AST, leaving 93.6% (IQI = 91.8, 97.5%) without AST benefit (overtreatment). The lowest expected amount of overtreatment was in the targeted and chemotherapy subgroup, with 86.5% (IQI = 83.4, 89.6%) overtreatment, and highest in the only endocrine treatment subgroup, with 96.7% (IQI = 96.0, 98.1%) overtreatment. Similar results were obtained using data from the USA, and guideline recommendations. Conclusion Based on PREDICT, AST prevents 10-year breast cancer death in 6.4% of the patients treated with AST. Consequently, AST yields no survival benefit to many treated patients. Especially improved personalization of endocrine therapy is relevant, as this therapy is widely used and is associated with the highest amount of overtreatment." @default.
• W4220653025 created "2022-04-03" @default.
• W4220653025 creator A5001652253 @default.
• W4220653025 creator A5009048417 @default.
• W4220653025 creator A5029655930 @default.
• W4220653025 creator A5033195086 @default.
• W4220653025 creator A5048017350 @default.
• W4220653025 creator A5076661327 @default.
• W4220653025 creator A5086826772 @default.
• W4220653025 creator A5090786009 @default.
• W4220653025 date "2022-03-03" @default.
• W4220653025 modified "2023-09-26" @default.
• W4220653025 title "Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA" @default.
• W4220653025 cites W1540562253 @default.
• W4220653025 cites W1701849548 @default.
• W4220653025 cites W1961026612 @default.
• W4220653025 cites W1980540927 @default.
• W4220653025 cites W2034100757 @default.
• W4220653025 cites W2044619726 @default.
• W4220653025 cites W2044702943 @default.
• W4220653025 cites W2057559260 @default.
• W4220653025 cites W2072013249 @default.
• W4220653025 cites W2115098571 @default.
• W4220653025 cites W2118728607 @default.
• W4220653025 cites W2126856198 @default.
• W4220653025 cites W2136592640 @default.
• W4220653025 cites W2141643495 @default.
• W4220653025 cites W2155097929 @default.
• W4220653025 cites W2155802351 @default.
• W4220653025 cites W2161743657 @default.
• W4220653025 cites W2169344399 @default.
• W4220653025 cites W2190954851 @default.
• W4220653025 cites W2267844613 @default.
• W4220653025 cites W2269350776 @default.
• W4220653025 cites W2293962048 @default.
• W4220653025 cites W2314200711 @default.
• W4220653025 cites W2410503781 @default.
• W4220653025 cites W2513942803 @default.
• W4220653025 cites W2517421365 @default.
• W4220653025 cites W2605630208 @default.
• W4220653025 cites W2617924944 @default.
• W4220653025 cites W2765118372 @default.
• W4220653025 cites W2788523770 @default.
• W4220653025 cites W2789729159 @default.
• W4220653025 cites W2791652737 @default.
• W4220653025 cites W2793290552 @default.
• W4220653025 cites W2805734855 @default.
• W4220653025 cites W2891381594 @default.
• W4220653025 cites W2891922165 @default.
• W4220653025 cites W2905139333 @default.
• W4220653025 cites W3045511120 @default.
• W4220653025 cites W3135974134 @default.
• W4220653025 doi "https://doi.org/10.1007/s10549-022-06550-2" @default.
• W4220653025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35239071" @default.
• W4220653025 hasPublicationYear "2022" @default.
• W4220653025 type Work @default.
• W4220653025 citedByCount "5" @default.
• W4220653025 countsByYear W42206530252022 @default.
• W4220653025 countsByYear W42206530252023 @default.
• W4220653025 crossrefType "journal-article" @default.
• W4220653025 hasAuthorship W4220653025A5001652253 @default.
• W4220653025 hasAuthorship W4220653025A5009048417 @default.
• W4220653025 hasAuthorship W4220653025A5029655930 @default.
• W4220653025 hasAuthorship W4220653025A5033195086 @default.
• W4220653025 hasAuthorship W4220653025A5048017350 @default.
• W4220653025 hasAuthorship W4220653025A5076661327 @default.
• W4220653025 hasAuthorship W4220653025A5086826772 @default.
• W4220653025 hasAuthorship W4220653025A5090786009 @default.
• W4220653025 hasBestOaLocation W42206530251 @default.
• W4220653025 hasConcept C119060515 @default.
• W4220653025 hasConcept C121608353 @default.
• W4220653025 hasConcept C126322002 @default.
• W4220653025 hasConcept C142724271 @default.
• W4220653025 hasConcept C143998085 @default.
• W4220653025 hasConcept C185926286 @default.
• W4220653025 hasConcept C187960798 @default.
• W4220653025 hasConcept C2780182762 @default.
• W4220653025 hasConcept C2908647359 @default.
• W4220653025 hasConcept C44249647 @default.
• W4220653025 hasConcept C530470458 @default.
• W4220653025 hasConcept C71924100 @default.
• W4220653025 hasConcept C99454951 @default.
• W4220653025 hasConceptScore W4220653025C119060515 @default.
• W4220653025 hasConceptScore W4220653025C121608353 @default.
• W4220653025 hasConceptScore W4220653025C126322002 @default.
• W4220653025 hasConceptScore W4220653025C142724271 @default.
• W4220653025 hasConceptScore W4220653025C143998085 @default.
• W4220653025 hasConceptScore W4220653025C185926286 @default.
• W4220653025 hasConceptScore W4220653025C187960798 @default.
• W4220653025 hasConceptScore W4220653025C2780182762 @default.
• W4220653025 hasConceptScore W4220653025C2908647359 @default.
• W4220653025 hasConceptScore W4220653025C44249647 @default.
• W4220653025 hasConceptScore W4220653025C530470458 @default.
• W4220653025 hasConceptScore W4220653025C71924100 @default.
• W4220653025 hasConceptScore W4220653025C99454951 @default.
• W4220653025 hasFunder F4320322777 @default.
• W4220653025 hasIssue "1" @default.
• W4220653025 hasLocation W42206530251 @default.

• next